top of page

Enterococcus faecium: The Multidrug-Resistant Hospital Superbug

  • Writer: Dr Harish M Nair
    Dr Harish M Nair
  • May 20
  • 3 min read

Enterococcus faecium has emerged as one of the most dangerous multidrug-resistant nosocomial pathogens worldwide. Although once considered a low-virulence intestinal commensal, it is now a major cause of hospital-acquired infections, particularly in critically ill and immunocompromised patients. This blog integrates microbiology, antimicrobial resistance, clinical medicine, and modern molecular insights from standard textbooks and journals.


Taxonomy and Classification

• Kingdom: Bacteria

• Phylum: Firmicutes (Bacillota)

• Class: Bacilli

• Order: Lactobacillales

• Family: Enterococcaceae

• Genus: Enterococcus

• Species: Enterococcus faecium



Previously classified among Group D streptococci, Enterococcus faecium is now recognized as a distinct enterococcal species.


Morphology

• Gram-positive cocci

• Arranged in pairs and short chains

• Non-spore-forming

• Facultative anaerobe

• Catalase negative



Microscopically resembles streptococci but demonstrates unique environmental survival abilities.


Culture Characteristics

Blood Agar:

• Usually non-hemolytic colonies

• Grayish-white appearance



Key Laboratory Features:


• Bile esculin positive

• Growth in 6.5% NaCl

• PYR positive

• Group D antigen positive



Capable of surviving harsh environmental conditions including disinfectants and prolonged desiccation.


Natural Habitat

Enterococcus faecium normally colonizes:


• Human intestine

• Gastrointestinal tract

• Female genital tract



It becomes pathogenic when host immunity is compromised or invasive medical procedures are performed.


Virulence Factors

1. Biofilm Formation


• Persistence on medical devices

• Antibiotic tolerance



2. Enterococcal Surface Protein (Esp)


• Colonization

• Biofilm enhancement



3. Adhesins


• Facilitate tissue attachment



4. Cytolysin


• Cell damage and virulence



5. Aggregation Substance


• Promotes plasmid exchange and adherence



Compared with Enterococcus faecalis, E. faecium is generally less virulent but significantly more drug resistant.


Diseases Caused

• Catheter-associated urinary tract infections

• Bacteremia

• Infective endocarditis

• Intra-abdominal infections

• Surgical site infections

• Device-associated infections

• Neonatal infections



A major pathogen in ICUs and transplant units.


Hospital Significance

Enterococcus faecium is strongly associated with healthcare settings.



Risk factors:


• Prolonged hospitalization

• Broad-spectrum antibiotic use

• ICU admission

• Indwelling catheters

• Immunosuppression



It survives on hospital surfaces for prolonged periods.


Laboratory Diagnosis

Specimens:


• Blood

• Urine

• Pus

• Catheter tips



Microscopy:


• Gram-positive cocci in pairs/chains



Identification:


• Bile esculin positivity

• Growth in 6.5% NaCl

• PYR positivity

• MALDI-TOF

• PCR-based methods


Antibiotic Resistance

Enterococcus faecium is notorious for multidrug resistance.



Major resistance patterns:


• Intrinsic cephalosporin resistance

• Ampicillin resistance

• High-level aminoglycoside resistance

• Vancomycin resistance



Vancomycin-resistant Enterococcus (VRE) is a major global threat.


Vancomycin Resistance

Resistance is mainly mediated by:


• vanA gene

• vanB gene



Mechanism:


• Altered peptidoglycan target

• Reduced vancomycin binding



Clinical importance:


• Limited therapeutic options

• High hospital transmission potential


Treatment

Treatment depends on susceptibility testing.



Common therapeutic agents:

• Linezolid

• Daptomycin

• Tigecycline

• Quinupristin-dalfopristin



Combination therapy may be required in severe infections.


Infection Control

Essential measures include:


• Hand hygiene

• Contact precautions

• Environmental cleaning

• Screening for VRE colonization

• Antimicrobial stewardship



Preventing hospital spread is critical.


Clinical Pearls

• Important multidrug-resistant nosocomial pathogen

• More resistant than Enterococcus faecalis

• Commonly associated with VRE

• Growth in 6.5% NaCl is characteristic

• Biofilm formation contributes to persistence


High-Yield PG Points

• Gram-positive cocci

• Group D streptococcus

• Bile esculin positive

• PYR positive

• Growth in 6.5% NaCl

• Major VRE organism

• Intrinsic cephalosporin resistance

• Important ICU pathogen


Modern Molecular Insights

Recent genomic studies demonstrate remarkable horizontal gene transfer and adaptability. Current research focuses on:


• VRE epidemiology

• Resistance gene transfer

• Hospital outbreak genomics

• Novel anti-enterococcal agents

• Phage therapy


Conclusion

Enterococcus faecium represents one of the greatest antimicrobial resistance challenges in modern medicine. Its ability to survive hospital environments and acquire multidrug resistance makes it a critical pathogen in healthcare-associated infections. Understanding its microbiology, resistance mechanisms, and infection control strategies is essential for clinicians and microbiologists.


Selected References

• Bailey & Scott’s Diagnostic Microbiology

• Koneman’s Color Atlas and Textbook of Diagnostic Microbiology

• Jawetz, Melnick & Adelberg’s Medical Microbiology

• Ananthanarayan & Paniker’s Textbook of Microbiology

• Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases

• Harrison’s Principles of Internal Medicine

• CDC Guidance on VRE

• Clinical Microbiology Reviews and ASM Journals

Comments


bottom of page